Kyrgyzstan - Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases
Since 2014, Kyrgyzstan Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases increased 2.1% year on year. At 1,403 Cases in 2019, the country was number 33 among other countries in Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases. Kyrgyzstan is overtaken by Peru, which was number 32 with 1,409 Cases and is followed by Mozambique with 1,388 Cases. India topped the ranking with 66,255 Cases in 2019, that is +13.6% compared to 2018. India, Russia and Russia respectively ranked number 2, 3 and 4 in this ranking. Republic of the Congo witnessed the best average annual growth at +171.1% per year, while Croatia recorded the worst performance at -100% per year.
Loading...
Date | Units (Cases) |
---|---|
2019 | 1,403.00 |
2018 | 1,370.00 |
2017 | 1,372.00 |
2016 | 1,236.00 |
2015 | 1,116.00 |
How does Kyrgyzstan rank in Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases?
# | 359 Countries | Units (Cases) | Last | YoY | 5‑years CAGR | ||
---|---|---|---|---|---|---|---|
1 |
#1
India
|
66,255 | 2019 | +13.6 % | +20.8 % | View data | |
3 |
#3
Russia
|
29,181 | 2019 | +5.0 % | +13.4 % | View data | |
31 |
#31
Angola
|
1,523 | 2019 | +134.7 % | +37.8 % | View data | |
33 |
#33
Kyrgyzstan
|
1,403 | 2019 | +2.4 % | +2.1 % | View data | |
34 |
#34
Mozambique
|
1,388 | 2019 | +19.9 % | +20.6 % | View data |